Afoxolaner 2.27% Chewable Tablet (28.3 Mg)
285 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
285
Total Reports
7
Deaths Reported
250.0%
Death Rate
Active Ingredients
Afoxolaner 2.27% Chewable Tablet (28.3 Mg)
Administration Routes
OralUnknown
Species Affected
Dog 284
Fox 1
Most Affected Breeds
Shih Tzu 29
Maltese 22
Crossbred Canine/dog 21
Dog (unknown) 17
Spaniel - King Charles Cavalier 16
Terrier - Yorkshire 16
Terrier - Jack Russell 15
Dachshund (unspecified) 9
Bichon Frise 7
Poodle - Miniature 7
Most Reported Reactions
Vomiting 85
Skin disorders NOS 54
Pruritus 42
Diarrhoea 33
Lethargy (see also Central nervous system depression in 'Neurological') 29
Lack of efficacy (ectoparasite) - tick NOS 28
Lack of efficacy (ectoparasite) - flea 27
Erythema (for urticaria see Immune SOC) 18
Anorexia 18
Behavioural disorder NOS 11
Apathy 11
Itching 10
Outcome Breakdown
Recovered/Normal
150 (52.6%)
Outcome Unknown
117 (41.1%)
Ongoing
9 (3.2%)
Died
6 (2.1%)
Recovered with Sequela
2 (0.7%)
Euthanized
1 (0.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.